市场调查报告书
商品编码
1467565
2024-2032 年按不孕原因、手术、服务、最终用户和地区分類的生育服务市场报告Fertility Services Market Report by Cause of Infertility, Procedure, Service, End-User, and Region 2024-2032 |
IMARC Group年,全球生育服务市场规模达到 407 亿美元。
生育服务是指为治疗不孕症而提供的程序。不孕症的定义是无法怀孕或足月怀孕。在男性中,其表现为精子数量低或男性荷尔蒙失衡的结果。对女性来说,不孕是指下视丘和脑下垂体等腺体缺乏正常功能,这些腺体可以刺激大脑中的激素,触发卵巢释放卵子。生育治疗包括增加怀孕机会的药物和手术。它们涉及生育药物、人工授精、体外受精(IVF)、卵子冷冻或卵母细胞冷冻保存、代孕、辅助生殖技术(ART)程序等。 他们协助不孕夫妇、单亲父母和 LGBT 群体成员计划生育计划。家庭。
以职业为导向的人口基数不断扩大,导致延迟怀孕现像日益普遍,这对市场成长做出了重大贡献。由于担心昂贵的托儿服务、学术或职业抱负以及缺乏经济稳定性等问题,人们往往选择晚生孩子,当他们更成熟和经济状况良好时。然而,过度的工作负荷和随之而来的压力,以及久坐的生活习惯,包括吸烟和吸毒,导致许多人出现不孕问题。此外,子宫内膜结核、多囊性卵巢症候群(PCOS)和可能导致不孕的性传染病(STD)等各种医疗疾病的盛行率不断上升,预计也将促进市场的成长。此外,个人意识的增强以及改善医疗设施的可近性进一步增加了已开发经济体和新兴经济体对这些服务的采用。其他因素,例如电视和线上入口网站上生育服务广告和促销的增加,以及可支配收入的增加和健康保险公司提供的灵活保险范围,也促进了市场的成长。
The global fertility services market size reached US$ 40.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 129.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.3% during 2024-2032.
Fertility services refer to the procedures provided as a treatment for infertility. Infertility is defined as the inability to conceive or carry a full-term pregnancy. Among males, it is identified by a low sperm count or is a result of hormonal imbalance in men. For females, infertility refers to the lack of proper functioning of glands such as hypothalamus and pituitary gland that stimulate hormones in the brain to trigger the ovaries to release an egg. Fertility treatments include medications and procedures that increase the chances of pregnancy. They involve fertility drugs, artificial insemination, In Vitro Fertilization (IVF), egg-freezing or oocyte cryopreservation, surrogacy, Assisted Reproductive Technology (ART) procedures, etc. They assist infertile couples, single parents and members of the LGBT community to plan a family.
The expanding career-oriented population base has led to the increasing prevalence of delayed pregnancies, which is contributing significantly to the market growth. Owing to concerns such as expensive childcare services, academic or career ambitions, and a lack of financial stability, people often opt to have children late in life when they are more mature and financially established. However, excessive workload and the accompanying stress along with sedentary lifestyle habits including smoking and consumption of drugs lead to infertility issues among many of them. Moreover, the rising prevalence of various medical ailments such as endometrial tuberculosis, polycystic ovarian syndrome (PCOS) and sexually transmitted diseases (STDs) that can cause infertility, is also projected to catalyze the growth of the market. Additionally, growing awareness among individuals and increasing accessibility to improved healthcare facilities have further increased the adoption of these services in both developed and emerging economies. Other factors such as increasing advertising and promotion of fertility services on televisions and online portals along with the rising disposable incomes and flexible coverage offered by health insurance companies are also augmenting the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global fertility services market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on cause of infertility, procedure, service, and end-user.
Male Infertility
Female Infertility
In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
Surrogacy
In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
Intrauterine Insemination (IUI)
Others
Fresh Non-Donor
Frozen Non-Donor
Egg and Embryo Banking
Fresh Donor
Frozen Donor
Fertility Clinics
Hospitals
Surgical Centres
Clinical Research Institutes
Cryobanks
Europe
North America
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Instituto Bernabeu Group, INVO Bioscience, Inc., Monash IVF Group, Apollo Hospitals Enterprise Ltd., CARE Fertility Group Ltd., Carolinas Fertility Institute, Genea Limited, The Cooper Companies, Inc., Virtus Health Group, Vitrolife Sweden AB, The Johns Hopkins Health System Corporation, Medicover AB (publ), OvaScience, Inc., Progyny, Inc., and Xytex Corporation.
IMARC Group's latest report provides a deep insight into the global fertility services market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the fertility services market in any manner.